A rating of 86 puts Y-mAbs Therapeutics Inc (YMAB) near the top of the Biotechnology industry according to InvestorsObserver. Y-mAbs Therapeutics Inc's score of 86 means it scores higher than 86% of stocks in the industry. Y-mAbs Therapeutics Inc also received an overall rating of 69, putting it above 69% of all stocks. Biotechnology is ranked 36 out of the 148 industries.
YMAB has an Overall Score of 69. Find out what this means to you and get the rest of the rankings on YMAB!
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 69 would rank higher than 69 percent of all stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Y-mAbs Therapeutics Inc Stock Today?
Y-mAbs Therapeutics Inc (YMAB) stock is trading at $13.08 as of 2:46 PM on Tuesday, Jun 21, a rise of $1.58, or 13.74% from the previous closing price of $11.50. The stock has traded between $11.94 and $13.20 so far today. Volume today is low. So far 299,643 shares have traded compared to average volume of 539,386 shares.
Click Here to get the full Stock Report for Y-mAbs Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
